GHSI guardionhealth.com: Business Value to Revenue

Guardion Health Sciences (GHSI) - corporate logo

Guardion Health Science (GHSI) is expanding its ophthalmological pharmaceutical presence through partnerships with clinics and nutritionists. The EV/Sales multiple trend visualizes the distribution synergy of Lumega-Z, with the metric currently standing at . Management is currently finalizing asset liquidation for shareholder payouts. Business revenues are based on pharmacy sales and a scientific foundation of drug efficacy, which directly impacts the stability of component supplies.

GHSI: Guardion Health Science EV/Sales Multiple 07/04/2022 - 11/19/2026

GHSI (Guardion Health Science): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental valuation:Guardion Health Science GHSI
Core merchandise of Guardion Health

Scalability constraints for Guardion Health Science (GHSI), driven by ophthalmology market saturation and high marketing expenditures, are hindering growth in operational efficiency. The EV/Sales multiple quantifies the total enterprise value relative to revenue excluding debt, enabling investors to distinguish the asset's fundamental strength from a speculative rally and recognize overvaluation risks in a timely manner by monitoring the chart.